DCW Ltd
NSE: DCW BSE: 500117
DCW Ltd is engaged in manufacture and sale of a diverse range of products with a focus on commodity chemicals, specialty chemicals and intermediate products.[1]
₹45.4
52W: ₹37.1 — ₹87.3
PE 27.8 · Book ₹36.4 · +25% vs bookMarket Cap₹1,339 Cr
Stock P/E27.8Price to Earnings
ROCE9.69%Return on Capital
ROE4.57%Return on Equity
Div. Yield0.21%Face Value ₹2
Strengths
- +Company has reduced debt.
Weaknesses
- −The company has delivered a poor sales growth of 7.92% over past five years.
- −Company has a low return on equity of 3.05% over last 3 years.
- −Dividend payout has been low at 7.33% of profits over last 3 years
- −Company's cost of borrowing seems high
Shareholding Pattern
Promoters45.44%
FIIs6.71%
DIIs0.01%
Public47.84%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 44.86% | 44.86% | 44.86% | 44.87%▲0.0 | 44.81%▼0.1 | 44.62%▼0.2 | 45.14%▲0.5 | 45.44%▲0.3 |
| FIIs | 7.35% | 11.25%▲3.9 | 11.35%▲0.1 | 10.82%▼0.5 | 10.05%▼0.8 | 9.18%▼0.9 | 8.57%▼0.6 | 6.71%▼1.9 |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 47.77% | 43.87%▼3.9 | 43.77%▼0.1 | 44.31%▲0.5 | 45.12%▲0.8 | 46.18%▲1.1 | 46.27%▲0.1 | 47.84%▲1.6 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 398 | 622 | 500 | 489 | 474 | 538 | 476 | 539 | 520 | 609 |
| Expenses | 378 | 558 | 454 | 453 | 417 | 482 | 422 | 481 | 475 | 544 |
| Operating Profit | 19 | 63 | 45 | 35 | 57 | 56 | 54 | 58 | 45 | 65 |
| OPM % | 5% | 10% | 9% | 7% | 12% | 10% | 11% | 11% | 9% | 11% |
| Net Profit | -12 | 15 | 7 | -1 | 13 | 11 | 11 | 14 | 5 | 18 |
| EPS ₹ | -0.42 | 0.52 | 0.23 | -0.04 | 0.45 | 0.38 | 0.39 | 0.47 | 0.17 | 0.61 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹2,144Cr, up 7.2% YoY. OPM at 10%.
Debt Position
Borrowings at ₹290Cr. Debt-to-equity ratio: 0.29x. Healthy balance sheet.
Capex Cycle
CWIP at ₹22Cr (2% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.01% (+0.00pp change). FIIs: 6.71% (-1.28pp change). Promoters hold 45.44%.
Margin & Efficiency
ROCE improving from 1% (Mar 2015) to 10% (Mar 2026). Working capital days: -34.
Valuation
PE 27.8x with 9.69% ROCE. Price is 25% above book value of ₹36.4. Dividend yield: 0.21%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 13 May - Newspaper Publication - Special Window for Re-lodgement of Transfer Requests of Physical Shares
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 13 May
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 6 May - DCW held earnings conference call on May 6, 2026 for Q4 and FY2026 results discussion.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 May
- Announcement under Regulation 30 (LODR)-Investor Presentation 5 May - Investor Presentation for the quarter and financial year ended March 31, 2026
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse